Clinical Trial Update: Efficacy Study of Blinatumomab Clean Up Early Residual Disease for Newly Diagnosed Pediatric B Lymphoblastic Leukemia [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update outlines a Phase 2/3 efficacy study of blinatumomab for newly diagnosed pediatric B-cell acute lymphoblastic leukemia. The study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• BLINCYTO (BLINATUMOMAB)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: B-Cell Lymphoblastic Leukemia | Phase 2, Phase 3 | Status: RECRUITING